Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (47)

1

Computer modeling of a potential agent against SARS-Cov-2 (COVID-19) protease

enthalten in: Proteins | 2020

von Lesk, A. | Konagurthu, A. | Allison, L. | +3

CommentOn: PLoS One. 2009;4(2):e4349. - PMID 19194505

2

Considerations on the Article "Antiviral and Anti-Inflammatory Properties of Ivermectin and its Potential Use in COVID-19"

enthalten in: Archivos de bronconeumologia | 2020

von Hernández-Vásquez, A. | Vargas-Fernández, R. | Azañedo, D.

CommentOn: Arch Bronconeumol. 2020 Dec;56(12):831. - PMID 32736876

3

Reply to "Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19"

enthalten in: Archivos de bronconeumologia | 2020

von Accinelli, R. | Portmann-Baracco, A. | Bryce-Alberti, M.

CommentOn: Arch Bronconeumol. 2020 May;56(5):291-297. - PMID 31740082

4

Hypothesis : Oxytocin is a direct COVID-19 antiviral

enthalten in: Medical hypotheses | 2020

von Diep, P. | Talash, K. | Kasabri, V.

CommentOn: Med Hypotheses. 2020 Jul;140:109785. - PMID 32344303

5

Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness

enthalten in: European journal of internal medicine | 2020

von Cavalli, G. | Dagna, L.

CommentOn: Eur J Intern Med. 2020 Dec;82:38-47. - PMID 32859477

6

Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals

enthalten in: Structure (London, England : 1993) | 2020

von Kneller, D. | Galanie, S. | Phillips, G. | +3

CommentOn: Nat Commun. 2020 Jun 24;11(1):3202. - PMID 32581217

7

Reply to "Antiviral and anti-inflammatory properties of ivermectinand its potential use in COVID-19"

enthalten in: Archivos de bronconeumologia | 2020

von Accinelli, R. | Portmann-Baracco, A. | Bryce-Alberti, M.

CommentOn: Arch Bronconeumol. 2020 Dec;56(12):832. - PMID 33051096

8

Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications : Expert Opinion

enthalten in: Therapeutic innovation & regulatory science | 2020

von Yamoah, P. | Alalbila, T. | Bangalee, V. | +1

CommentOn: Clin Infect Dis. 2020 Jul 28;71(15):732-739. - PMID 32150618

9

Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)

enthalten in: Antimicrobial agents and chemotherapy | 2020

von McCullough, P.

CommentOn: Antimicrob Agents Chemother. 2020 Nov 17;64(12):. - PMID 32958718

10

Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19

enthalten in: Journal of medical virology | 2020

von Chong, V. | Chong, P. | Metussin, D. | +4

CommentOn: J Med Virol. 2020 Jul;92(7):776-785. - PMID 32297988

1
2
3
4
5
Nächster »
[5]